cabazitaxel
Showing 1 - 25 of 65
Prostate Cancer Trial in Houston (ADI-PEG 20, Cabazitaxel, Carboplatin)
Not yet recruiting
- Prostate Cancer
- ADI-PEG 20
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Oct 16, 2023
Prostate Cancer Metastatic Trial (Pembrolizumab, Carboplatin, Cabazitaxel)
Not yet recruiting
- Prostate Cancer Metastatic
- Pembrolizumab
- +2 more
- (no location specified)
Sep 29, 2022
Prostate Cancer Aggressiveness, Prostate Carcinoma Trial in Houston (Cabazitaxel, Carboplatin, Prednisone 5Mg)
Active, not recruiting
- Prostate Cancer Aggressiveness
- Prostate Carcinoma
- Cabazitaxel
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 5, 2022
Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Melbourne (Cabazitaxel, 177Lu-PSMA-617)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- mCRPC
- Cabazitaxel
- 177Lu-PSMA-617
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Jul 20, 2022
Testicular Cancer Trial in Worldwide (cabazitaxel)
Recruiting
- Testicular Cancer
- cabazitaxel
-
Copenhagen, Denmark
- +4 more
Jul 18, 2022
Prostate Cancer Trial in Providence (Cabazitaxel)
Terminated
- Prostate Cancer
- Cabazitaxel
-
Providence, Rhode IslandMiriam Hospital
Feb 23, 2022
Urothelial Carcinoma of the Urinary Bladder Trial in New York (Cabazitaxel, Gemcitabine, Cisplatin)
Recruiting
- Urothelial Carcinoma of the Urinary Bladder
- Cabazitaxel
- +2 more
-
New York, New YorkColumbia University Medical Center- HIP
Feb 3, 2022
Prostate Cancer Trial in United States (Cabazitaxel, Carboplatin, Abiraterone)
Recruiting
- Prostate Cancer
- Cabazitaxel
- +3 more
-
Phoenix, Arizona
- +7 more
Apr 12, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Portland, Seattle
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +3 more
- Cabazitaxel
- +4 more
-
Portland, Oregon
- +2 more
Jun 24, 2022
Adenocarcinoma of Prostate, Progression of Prostate Cancer Trial in Villejuif (Cabazitaxel, Pelvic radiotherapy, prostate
Active, not recruiting
- Adenocarcinoma of Prostate
- Progression of Prostate Cancer
- Cabazitaxel
- +2 more
-
Villejuif, FranceInstitut Gustave Roussy
Oct 5, 2021
Progressive Metastatic Castrate-Resistant Prostate Cancer Trial in Worldwide (AZD4635, Durvalumab, Cabazitaxel)
Active, not recruiting
- Progressive Metastatic Castrate-Resistant Prostate Cancer
- AZD4635
- +2 more
-
Sacramento, California
- +15 more
Mar 22, 2022
Dedifferentiated Liposarcoma Trial in Worldwide (Cabazitaxel)
Completed
- Dedifferentiated Liposarcoma
- Cabazitaxel
-
Antwerpen, Belgium
- +10 more
Sep 10, 2021
Circulating Tumor Cell, Metastatic Prostate Cancer Trial in Netherlands (Cabazitaxel, Antihistamine, Corticosteroid)
Active, not recruiting
- Circulating Tumor Cell
- Metastatic Prostate Cancer
- Cabazitaxel
- +4 more
-
Delft, Netherlands
- +8 more
Aug 19, 2021
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Lymphadenopathy Trial in Detroit, Houston
Completed
- Castration Levels of Testosterone
- +6 more
- Cabazitaxel
- +2 more
-
Detroit, Michigan
- +1 more
Jul 29, 2021
Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston
Recruiting
- Aggressive Variant Prostate Carcinoma
- +5 more
- Cabazitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 10, 2022
Metastatic Prostate Cancer in Pirkanmaa Hospital District in
Not yet recruiting
- Metastatic Castration Sensitive Prostate Cancer (mCSPC)
- Metastatic Castration Resistant Prostate Cancer (mCRPC)
- abiraterone
- +10 more
- (no location specified)
Jan 17, 2023
Prostate Cancer Trial (Cabazitaxel)
Not yet recruiting
- Prostate Cancer
- Cabazitaxel
- (no location specified)
Jan 4, 2021
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston,
Active, not recruiting
- Castration Levels of Testosterone
- +4 more
- Abiraterone Acetate
- +6 more
-
Houston, Texas
- +2 more
Feb 11, 2022
Hormone-Resistant Prostate Cancer, Stage IV Prostate Adenocarcinoma Trial in Sacramento (Cabazitaxel, Prednisone)
Terminated
- Hormone-Resistant Prostate Cancer
- Stage IV Prostate Adenocarcinoma
- Cabazitaxel
- Prednisone
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Jan 21, 2021
Ovarian Cancer Trial in Vejle (Cabazitaxel)
Completed
- Ovarian Cancer
- Cabazitaxel
-
Vejle, DenmarkVejle Hospital, Department of Oncology
Oct 6, 2020
Prostate Cancer Trial in Philadelphia (drug, radiation, genetic)
Active, not recruiting
- Prostate Cancer
- Cabazitaxel
- +3 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Dec 7, 2020
Prostate Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Cabazitaxel)
Active, not recruiting
- Prostate Cancer
- Nivolumab
- +3 more
-
Tucson, Arizona
- +59 more
Dec 22, 2022
Prostate Cancer Trial in New York (Abiraterone acetate, Prednisone, Radium-223 dichloride)
Completed
- Prostate Cancer
- Abiraterone acetate
- +5 more
-
New York, New York
- +1 more
Dec 10, 2021
Prostate Cancer Metastatic, Metastasis Trial in Netherlands (Cabazitaxel, Abiraterone, Enzalutamide)
Completed
- Prostate Cancer Metastatic
- Metastasis
- Cabazitaxel
- +2 more
-
Alkmaar, Netherlands
- +18 more
Apr 14, 2022